Filled for bankrupcy in Nov 2022
ALNA - Allena Pharmaceuticals, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Newton,
United States
Type: Equity
ALNA price evolution
ALNA
| (in millions $) | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 | 30 Sep 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $6.59 | $8.89 | $29.99 | $40.42 |
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $16.49 | $20.2 | $33.01 | $41.95 |
| Long term investments | ||||
| Property, plant & equipment | $1.2 | $1.41 | $1.63 | $1.79 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $1.32 | $1.53 | $1.75 | $1.92 |
| Total investments | ||||
| Total assets | $17.81 | $21.73 | $34.76 | $43.87 |
| Current liabilities | ||||
| Accounts payable | $2.27 | $3.08 | $1.03 | $3.03 |
| Deferred revenue | ||||
| Short long term debt | $5.28 | $5.35 | $10.17 | $0.3 |
| Total current liabilities | $10.43 | $10.12 | $15.68 | $7.67 |
| Long term debt | $0.21 | $10.17 | ||
| Total noncurrent liabilities | $3.65 | $0.21 | $10.17 | |
| Total debt | $5.28 | $5.35 | $10.38 | $10.47 |
| Total liabilities | $14.07 | $10.12 | $15.89 | $17.84 |
| Shareholders' equity | ||||
| Retained earnings | -$266.7 | -$258.26 | -$246.45 | -$236.09 |
| Other shareholder equity | ||||
| Total shareholder equity | $3.74 | $11.62 | $18.87 | $26.03 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $29.99 | $35.04 | $30.01 | $61.64 |
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $33.01 | $37.25 | $33.03 | $64.47 |
| Long term investments | ||||
| Property, plant & equipment | $1.63 | $1.56 | $0.95 | $0.51 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $1.75 | $1.68 | $1.07 | $0.76 |
| Total investments | ||||
| Total assets | $34.76 | $38.93 | $34.11 | $65.23 |
| Current liabilities | ||||
| Accounts payable | $1.03 | $2.41 | $3.05 | $2.14 |
| Deferred revenue | ||||
| Short long term debt | $10.17 | $0.29 | $4.49 | |
| Total current liabilities | $15.68 | $6.12 | $10.91 | $5.76 |
| Long term debt | $0.21 | $10.24 | $6 | $9.98 |
| Total noncurrent liabilities | $0.21 | $10.24 | $6 | $10.01 |
| Total debt | $10.38 | $10.53 | $10.49 | $9.98 |
| Total liabilities | $15.89 | $16.36 | $16.91 | $15.77 |
| Shareholders' equity | ||||
| Retained earnings | -$246.45 | -$197.79 | -$164.94 | -$117.61 |
| Other shareholder equity | ||||
| Total shareholder equity | $18.87 | $22.57 | $17.2 | $49.46 |
| (in millions $) | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 | 30 Sep 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $3.98 | $7.76 | $8.01 | $9.02 |
| Selling, general & administrative | $2.94 | $3.8 | $2.12 | $3.41 |
| Total operating expenses | $6.92 | $11.56 | $10.12 | $12.43 |
| Operating income | -$6.92 | -$11.56 | -$10.12 | -$12.43 |
| Income from continuing operations | ||||
| EBIT | -$8.32 | -$11.56 | -$10.13 | -$12.44 |
| Income tax expense | ||||
| Interest expense | $0.12 | $0.25 | $0.24 | $0.25 |
| Net income | ||||
| Net income | -$8.44 | -$11.81 | -$10.36 | -$12.69 |
| Income (for common shares) | -$8.44 | -$11.81 | -$10.36 | -$12.69 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $34.97 | $20.38 | $37.24 | $26.38 |
| Selling, general & administrative | $12.68 | $11.6 | $9.68 | $9.22 |
| Total operating expenses | $47.65 | $31.99 | $47.52 | $35.59 |
| Operating income | -$47.65 | -$31.99 | -$47.52 | -$35.59 |
| Income from continuing operations | ||||
| EBIT | -$47.69 | -$32.34 | -$47.61 | -$36.22 |
| Income tax expense | ||||
| Interest expense | $0.98 | $0.51 | -$0.27 | -$0.57 |
| Net income | ||||
| Net income | -$48.66 | -$32.84 | -$47.34 | -$35.65 |
| Income (for common shares) | -$48.66 | -$32.84 | -$47.34 | -$35.65 |
| (in millions $) | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 | 30 Sep 2021 |
|---|---|---|---|---|
| Net income | -$8.44 | -$11.81 | -$10.36 | -$12.69 |
| Operating activities | ||||
| Depreciation | $0.21 | $0.22 | $0.21 | $0.19 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.56 | $0.62 | $0.81 | $1.03 |
| Total cash flows from operations | -$4.56 | -$20.04 | -$12.8 | -$11.48 |
| Investing activities | ||||
| Capital expenditures | -$0.03 | -$0.18 | ||
| Investments | ||||
| Total cash flows from investing | -$0.03 | -$0.18 | ||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $3.94 | $2.4 | $25.43 | |
| Net borrowings | -$5 | |||
| Total cash flows from financing | $2.25 | -$1.06 | $2.4 | $25.43 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$2.31 | -$21.09 | -$10.43 | $13.77 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Net income | -$48.66 | -$32.84 | -$47.34 | -$35.65 |
| Operating activities | ||||
| Depreciation | $0.73 | $0.77 | $0.65 | $0.08 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $3.67 | $4.05 | $2.99 | $2.05 |
| Total cash flows from operations | -$45.68 | -$28.16 | -$43.63 | -$31.84 |
| Investing activities | ||||
| Capital expenditures | -$0.67 | -$0.63 | -$0.12 | -$0.32 |
| Investments | ||||
| Total cash flows from investing | -$0.67 | -$0.63 | -$0.12 | -$0.32 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $41.29 | $34.06 | $12.15 | -$0.14 |
| Net borrowings | -$0.21 | -$0.53 | ||
| Total cash flows from financing | $41.29 | $33.83 | $12.12 | -$0.69 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$5.05 | $5.04 | -$31.64 | -$32.85 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 107.73M |
| Revenue | $0.00 |
|---|---|
| EBITDA | -$41.62M |
| EBIT | -$42.45M |
| Net Income | -$43.30M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | 0.00 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.00 |
| Book/Share | 0.03 |
| Cash/Share | 0.06 |
| EPS | -$0.40 |
|---|---|
| ROA | -146.58% |
| ROE | -287.46% |
| Debt/Equity | 0.84 |
|---|---|
| Net debt/EBITDA | -0.18 |
| Current ratio | 1.58 |
| Quick ratio | 1.58 |